About John Cammack
John Cammack is a director at Pearl Diagnostics.
John Cammack first appears on SEC filings in 2022.
Experience
This experience comes from John Cammack's profile and from SEC filings. For roles taken from filings, the years are when the filings name John Cammack in the role, so the role may have started earlier or lasted longer.
AD
Astek Diagnostics Current
Board Observer
2023 – Present
Pearl Diagnostics, Inc. Current
Member Board Of Directors
2022 – Present · Baltimore, MD
Urine tests help clinicians diagnose lung infections.
PL
Propel Baltimore Fund II LP Current
Member of Investment Committee
2022 – Present
DF
Dudley Fund Current
Member of Investment Committee
2022 – Present
KL
Kingcedar Holdings, LLC Current
Managing Partner
2014 – Present
BC
Bridge Builders Collaborative
Partner
2016 – 2023
SI
SignalVine
Member Board Of Directors
2018 – 2022
CS
Calvert Education Services
Member Board Of Directors
2013 – 2019
FA
FactoryFour
Member Board Of Directors
2016 – 2018
JV
Johns Hopkins Technology Ventures
Mentor-in-Residence
2015 – 2018
TG
T. Rowe Price Group
Senior Executive
1991 – 2009
Key Colleagues at Startups
The people John Cammack works with at each company, as listed on that company's latest Form D.
Pearl Diagnostics, Inc. · Form D, Apr 21, 2026
